Brain
MINDSET-1 DUTCH
For people with MCI or mild Alzheimer's, a BMI of 18–40 and an MMSE score of 12–22.…
*Would you prefer to call? We will take the time to answer your questions.
Two minutes. After registering, an investigator will call you within a week to discuss whether an investigation is suitable for you.
Alzheimer is a brain disease in which proteins build up in the brain. It is the most common cause of dementia: in about seven out of ten cases, Alzheimer’s is the cause. The disease begins years before someone notices anything, and progresses differently in everyone.
Alzheimer's starts slowly. Often a close relative is the first to notice it.
Dementia is a collective term for a group of symptoms: memory loss, difficulty thinking and problems in daily life. Alzheimer's is the disease that is responsible for most cases of these symptoms. There are also other causes, such as vascular dementia or dementia with Lewy bodies.
The difference matters. Having Alzheimer's without already having dementia is exactly the phase in which research can make the most difference.
The average life expectancy after diagnosis is about eight years, but it varies greatly from person to person.
The disease has started, but you still don’t notice anything. This can take ten to twenty years. With a brain scan or blood test, the disease can sometimes be seen, but in ordinary care it rarely happens.
There is no online test that can diagnose Alzheimer's. The diagnosis is made by a doctor, usually in a memory clinic or at a neurologist's office. This involves a combination of an interview, memory and thinking tests, blood tests, a brain scan, and sometimes an examination of the cerebrospinal fluid.
There are medications that can alleviate the symptoms. In addition, recent developments have created means that address the disease itself. These medications are not covered by the basic health insurance in the Netherlands. Through participation in research, you can sometimes be among the first to access a new medication, with additional monitoring and guidance.
Every means available today against Alzheimer’s has come about because someone participated in research. In the early stages, when the disease is not yet advanced, research has the best chance of making a difference. Those who participate now are contributing to the treatment of tomorrow. Not only for themselves, but for everyone who comes after them.
You register using a short form: two minutes, at home, no medical questions. You are only asking for information with this.
An investigator will contact you within a week. A few questions about your situation, room for your questions.
If it suits you, you can come to one of our locations for an interview with the research doctor. You decide together which research suits you. Only then do you decide.
Your research does not take place in a hospital, but at Progress: with a dedicated team that you know by name, in a center close to home. Your own GP and specialist will be informed as soon as you start participating. Your own treatment will continue as usual.
Two minutes, at home. After registering, we will discuss together which research suits you best.
I’m participating for myself, but also for the next generation, for the people who come after me. I just want to help find something.
Anton
Participant in Alzheimer's research
In some studies, we ask for a study partner: someone you know well and see regularly, who comes along to the visits. Travel and parking costs are reimbursed for both of you.
Not everyone who signs up can participate. Each research project sets strict conditions. Feel free to sign up, even if you have doubts; we will look into it together to see if it is possible.
All ongoing studies at Progress
What is drug research, and what does it benefit you?
This is how to participate, step by step
Two minutes. After registering, an investigator will call you within a week and we will discuss which study suits you best.
Brain
For people with MCI or mild Alzheimer's, a BMI of 18–40 and an MMSE score of 12–22.…
*Would you prefer to call? We will take the time to answer your questions.
Brain
In this study, we examine whether efavirenz is safe and effective in people with early Alzheimer's disease.…
*Would you prefer to call? We will take the time to answer your questions.
Brain
In this study, we examine whether KarXT, together with KarX-EC, can help people with...
*Would you prefer to call? We will take the time to answer your questions.
Brain
In this study, we are looking at whether the drug DNL628 is safe for people with early Alzheimer’s disease…
*Would you prefer to call? We will take the time to answer your questions.
Brain
In this study, we are looking at whether RO7812653 is safe. The drug is being compared with a placebo…
*Would you prefer to call? We will take the time to answer your questions.
Brain
The goal of this study is to investigate the safety of the investigational drug ALN-5288 in patients with…
*Would you prefer to call? We will take the time to answer your questions.
Brain
In this study, we examine whether MK-1167 is safe and effective in people with mild to...
An investigator will call you within a week.
Brain
A Phase II, randomized, double-blind, placebo-controlled, parallel group, multicenter study to evaluate the efficacy and safety of...
An investigator will call you within a week.
Brain
This study tests the safety and efficacy of AR1001 in people with Alzheimer's disease...
An investigator will call you within a week.
Brain
This study investigates the safety and efficacy of MK-1167 as an adjunct treatment in people with mild…
An investigator will call you within a week.
Brain
The goal of this study is to understand how safe the new investigational drug called Trontinemab is…
An investigator will call you within a week.
Perhaps you are not looking for yourself, but for someone who stands behind you. You see things that the other person does not notice, or that are overlooked. This often happens: in Alzheimer's disease, someone cannot always assess themselves well. That is part of the disease.
You are welcome to call us for a consultation, even if a diagnosis has not yet been made. And you are welcome to attend every appointment. Travel and parking costs are reimbursed.
You fill in the form on behalf of your loved one, or you call:
Dementia is a collective term for symptoms such as memory loss and difficulty thinking. Alzheimer's is the disease that is often behind these symptoms. There are also other causes, such as vascular dementia or dementia with Lewy bodies.
There is no online test that can diagnose Alzheimer's. The diagnosis is made by a doctor, through a combination of an interview, memory tests, blood tests, and a brain scan.
There are medications that alleviate the symptoms. In addition, recently, methods have been developed that address the disease itself. These methods are not covered by the basic health insurance. By participating in research, you may sometimes be among the first to have access to a new medication.
Alzheimer's is a brain disease in which the proteins amyloid and tau accumulate in the brain. It is the most common cause of dementia. The disease begins years before someone notices anything.
Two minutes, at home. After signing up, an investigator will call you within a week.
Would you prefer to call directly?
Calling is free of charge, even if you just want to ask something.